Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Breast Neoplasms 2Motor Activity 1Inflammation 1Colonic Neoplasms 1

Interventions

Specimen Handling 641pembrolizumab 585Magnetic Resonance Spectroscopy 555Carboplatin 431Cyclophosphamide 381Cisplatin 379Biopsy 376Nivolumab 315Paclitaxel 314Gemcitabine 308Radiotherapy 286Bevacizumab 235Dexamethasone 218fludarabine 206Docetaxel 194durvalumab 189Oxaliplatin 189venetoclax 187Rituximab 175Fluorouracil 175atezolizumab 172Pemetrexed 167Capecitabine 164Radiosurgery 162Doxorubicin 162Radiation 160Ipilimumab 146Lenalidomide 140Leucovorin 138Etoposide 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Calcium × 90 days × Clear all
NCT07534852 2026-04-16

NIMA

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Phase NA Recruiting
120 enrolled
Gastrointestinal

Colonic Neoplasms, Inflammation, Motor Activity

NCT04067726 2026-03-31

TRIDENT

Washington University School of Medicine

Phase 2 Active not recruiting
210 enrolled
Breast

Breast Neoplasms

NCT01480869 2026-03-12

VITACAL

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 3 Completed
215 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡